| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Immunology, Mayo Graduate and Medical Schools, Mayo Clinic, Rochester, MN 55905
The Vav protooncogene is a multidomain protein involved in the regulation of IL-2 gene transcription in T cells and the development of cell-mediated killing by cytotoxic lymphocytes. We have investigated the differential roles that specific protein subdomains within the Vav protooncogene have in the development of these two distinct cellular processes. Interestingly, a calponin homology (CH) domain mutant of Vav (CH-) fails to enhance NF-AT/AP-1-mediated gene transcription but is still able to regulate the development of cell-mediated killing. The inability of the CH- mutant to enhance NF-AT/AP-1-mediated transcription appears to be secondary to defective intracellular calcium, because 1) the CH- mutant has significantly reduced TCR-initiated calcium signaling, and 2) treatment with the calcium ionophore ionomycin or cotransfection with activated calcineurin restores NF-AT/AP-1-mediated gene transcription. The pleckstrin homology (PH) domain of Vav has also been implicated in regulating Vav activation. We found that deletion of the PH domain of Vav yields a protein that can neither enhance gene transcription from the NF-AT/AP-1 reporter nor enhance TCR- or FcR-mediated killing. In contrast, the PH deletion mutant of Vav is able to regulate the development of natural cytotoxicity, indicating a functional dichotomy for the PH domain in the regulation of these two distinct forms of killing. Lastly, mutation of three tyrosines (Y142, Y160, and Y174) within the acidic domain of Vav has revealed a potential negative regulatory site. Replacement of all three tyrosines with phenylalanine results in a hyperactive protein that increases NF-AT/AP-1-mediated gene transcription and enhances cell-mediated cytotoxicity. Taken together, these data highlight the differential roles that specific subdomains of Vav have in controlling distinct cellular functions. More broadly, the data suggest that separate lymphocyte functions can potentially be modulated by domain-specific targeting of Vav and other critical intracellular signaling molecules.
This article has been cited by other articles:
|
|
 |
|
  Z. Zhou, J. Yin, Z. Dou, J. Tang, C. Zhang, and Y. Cao The Calponin Homology Domain of Vav1 Associates with Calmodulin and Is Prerequisite to T Cell Antigen Receptor-induced Calcium Release in Jurkat T Lymphocytes J. Biol. Chem., August 10, 2007; 282(32): 23737 - 23744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Nolz, M. E. Fernandez-Zapico, and D. D. Billadeau TCR/CD28-Stimulated Actin Dynamics Are Required for NFAT1-Mediated Transcription of c-rel Leading to CD28 Response Element Activation J. Immunol., July 15, 2007; 179(2): 1104 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Fumagalli, H. Zhang, A. Baruzzi, C. A. Lowell, and G. Berton The Src Family Kinases Hck and Fgr Regulate Neutrophil Responses to N-Formyl-Methionyl-Leucyl-Phenylalanine J. Immunol., March 15, 2007; 178(6): 3874 - 3885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Ming, S. Li, D. D. Billadeau, L. A. Quilliam, and M. C. Dinauer The Rac Effector p67phox Regulates Phagocyte NADPH Oxidase by Stimulating Vav1 Guanine Nucleotide Exchange Activity Mol. Cell. Biol., January 1, 2007; 27(1): 312 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Miletic, K. Sakata-Sogawa, M. Hiroshima, M. J. Hamann, T. S. Gomez, N. Ota, T. Kloeppel, O. Kanagawa, M. Tokunaga, D. D. Billadeau, et al. Vav1 Acidic Region Tyrosine 174 Is Required for the Formation of T Cell Receptor-induced Microclusters and Is Essential in T Cell Development and Activation J. Biol. Chem., December 15, 2006; 281(50): 38257 - 38265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Masilamani, C. Nguyen, J. Kabat, F. Borrego, and J. E. Coligan CD94/NKG2A Inhibits NK Cell Activation by Disrupting the Actin Network at the Immunological Synapse J. Immunol., September 15, 2006; 177(6): 3590 - 3596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Upshaw, R. A. Schoon, C. J. Dick, D. D. Billadeau, and P. J. Leibson The Isoforms of Phospholipase C-{gamma} Are Differentially Used by Distinct Human NK Activating Receptors J. Immunol., July 1, 2005; 175(1): 213 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dombroski, R. A. Houghtling, C. M. Labno, P. Precht, A. Takesono, N. J. Caplen, D. D. Billadeau, R. L. Wange, J. K. Burkhardt, and P. L. Schwartzberg Kinase-Independent Functions for Itk in TCR-Induced Regulation of Vav and the Actin Cytoskeleton J. Immunol., February 1, 2005; 174(3): 1385 - 1392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Vigorito, G. Bardi, J. Glassford, E. W.-F. Lam, E. Clayton, and M. Turner Vav-Dependent and Vav-Independent Phosphatidylinositol 3-Kinase Activation in Murine B Cells Determined by the Nature of the Stimulus J. Immunol., September 1, 2004; 173(5): 3209 - 3214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Katzav Vav1: an oncogene that regulates specific transcriptional activation of T cells Blood, April 1, 2004; 103(7): 2443 - 2451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Stebbins, C. Watzl, D. D. Billadeau, P. J. Leibson, D. N. Burshtyn, and E. O. Long Vav1 Dephosphorylation by the Tyrosine Phosphatase SHP-1 as a Mechanism for Inhibition of Cellular Cytotoxicity Mol. Cell. Biol., September 1, 2003; 23(17): 6291 - 6299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Khurana and P. J. Leibson Regulation of lymphocyte-mediated killing by GTP-binding proteins J. Leukoc. Biol., March 1, 2003; 73(3): 333 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Michel and O. Acuto CD28 Costimulation: A Source of Vav-1 for TCR Signaling with the Help of SLP-76? Sci. Signal., August 6, 2002; 2002(144): pe35 - pe35. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zou, C. Ayling, J. Xian, T. A. Piper, P. J. Barker, and M. Bruggemann Truncation of the {micro} heavy chain alters BCR signalling and allows recruitment of CD5+ B cells Int. Immunol., December 1, 2001; 13(12): 1489 - 1499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Jevremovic, D. D. Billadeau, R. A. Schoon, C. J. Dick, and P. J. Leibson Regulation of NK Cell-Mediated Cytotoxicity by the Adaptor Protein 3BP2 J. Immunol., June 15, 2001; 166(12): 7219 - 7228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Chuang, H.-T. K. Pham, P. R. Kumaresan, and P. A. Mathew A Prominent Role for Activator Protein-1 in the Transcription of the Human 2B4 (CD244) Gene in NK Cells J. Immunol., May 15, 2001; 166(10): 6188 - 6195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Kaminuma, M. Deckert, C. Elly, Y.-C. Liu, and A. Altman Vav-Rac1-Mediated Activation of the c-Jun N-Terminal Kinase/c-Jun/AP-1 Pathway Plays a Major Role in Stimulation of the Distal NFAT Site in the Interleukin-2 Gene Promoter Mol. Cell. Biol., May 1, 2001; 21(9): 3126 - 3136. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. D. Billadeau, S. M. Mackie, R. A. Schoon, and P. J. Leibson The Rho Family Guanine Nucleotide Exchange Factor Vav-2 Regulates the Development of Cell-mediated Cytotoxicity J. Exp. Med., August 8, 2000; 192(3): 381 - 392. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
